{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:44:11Z","timestamp":1790765051790,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clineu-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clineuro.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:15:10Z","timestamp":1492647310000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis"],"prefix":"10.1016","volume":"157","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuZhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clineuro.2017.04.012_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","article-title":"Seropositive myasthenia gravis: a nationwide epidemiologic study","volume":"73","author":"Heldal","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2017.04.012_bib0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/1756285615605700","article-title":"Future perspectives in target-specific immunotherapies of myasthenia gravis","volume":"8","author":"Dalakas","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"8","key":"10.1016\/j.clineuro.2017.04.012_bib0015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI14255","article-title":"Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice","volume":"109","author":"Yang","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.clineuro.2017.04.012_bib0020","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.clineuro.2017.04.012_bib0025","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/eji.200737973","article-title":"CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity","volume":"38","author":"Bai","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/sji.12057","article-title":"Expression of interleukin-22 in myasthenia gravis","volume":"78","author":"Zheng","year":"2013","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2017.04.012_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle. Nerve."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-013-1460-3","article-title":"Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis","volume":"35","author":"Li","year":"2014","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.clineuro.2017.04.012_bib0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1517\/13543784.2011.578068","article-title":"A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases","volume":"20","author":"Arulkumaran","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.clineuro.2017.04.012_bib0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1615\/CritRevImmunol.v26.i6.30","article-title":"Regulation of immune response by P2X7 receptor","volume":"26","author":"Chen","year":"2006","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clineuro.2017.04.012_bib0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-9255-4-5","article-title":"The role of the purinergic P2X7 receptor in inflammation","volume":"4","author":"Lister","year":"2007","journal-title":"J. Inflamm. (Lond)."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jmcb\/mjr042","article-title":"Inflammasome-IL-1-Th17 response in allergic lung inflammation","volume":"4","author":"Besnard","year":"2012","journal-title":"J. Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.clineuro.2017.04.012_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/mutage\/get007","article-title":"Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population","volume":"28","author":"Chen","year":"2013","journal-title":"Mutagenesis"},{"issue":"3","key":"10.1016\/j.clineuro.2017.04.012_bib0075","first-page":"354","article-title":"The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sj\u00f6gren's syndrome and its correlation with anxiety and depression","volume":"32","author":"Xie","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"35","key":"10.1016\/j.clineuro.2017.04.012_bib0080","doi-asserted-by":"crossref","first-page":"9525","DOI":"10.1523\/JNEUROSCI.0579-07.2007","article-title":"P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis","volume":"27","author":"Matute","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbadis.2013.10.012","article-title":"Prophylactic systemic P2X7 receptor blockade prevents experimental colitis","volume":"1842","author":"Marques","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.clineuro.2017.04.012_bib0090","doi-asserted-by":"crossref","first-page":"e116253","DOI":"10.1371\/journal.pone.0116253","article-title":"Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats","volume":"9","author":"Antonioli","year":"2014","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.clineuro.2017.04.012_bib0095","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman DB:","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.clineuro.2017.04.012_bib0100","first-page":"497","article-title":"Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients","volume":"38","author":"Osserman","year":"1971","journal-title":"Mt. Sinai J. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2017.04.012_bib0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","article-title":"Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis","volume":"247","author":"Sharshar","year":"2000","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2017.04.012_bib0110","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","article-title":"The P2X7 receptor: a key player in IL-1 processing and release","volume":"176","author":"Ferrari","year":"2006","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clineuro.2017.04.012_bib0115","doi-asserted-by":"crossref","first-page":"C1189","DOI":"10.1152\/ajpcell.2000.279.4.C1189","article-title":"Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors","volume":"279","author":"Gu","year":"2000","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"5\u20136","key":"10.1016\/j.clineuro.2017.04.012_bib0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000336628","article-title":"Characterizing the presence and sensitivity of the P2X7 receptor in different compartments of the gut","volume":"4","author":"de Campos NE1","year":"2012","journal-title":"J. Innate. Immun."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bmc.2013.10.054","article-title":"Purinergic receptor P2X7: a novel target for anti-inflammatory therapy","volume":"22","author":"Mehta","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.clineuro.2017.04.012_bib0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrd1342","article-title":"Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention","volume":"3","author":"Braddock","year":"2004","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"4","key":"10.1016\/j.clineuro.2017.04.012_bib0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/1521-4141(200101)31:1<225::AID-IMMU225>3.0.CO;2-0","article-title":"Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis","volume":"31","author":"Huang","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2017.04.012_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2004.10.002","article-title":"Decreased pro-inflammatory cytokine production 29. by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes\/macrophages","volume":"69","author":"Hougee","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.clineuro.2017.04.012_bib0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.clineuro.2017.04.012_bib0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tips.2007.07.002","article-title":"Liaisons dangereuses: P2X(7) and the inflammasome","volume":"28","author":"Di Virgilio","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.clineuro.2017.04.012_bib0160","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI78085","article-title":"Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity","volume":"125","author":"Burkett","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7090","key":"10.1016\/j.clineuro.2017.04.012_bib0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clineuro.2017.04.012_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","author":"Aricha","year":"2011","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.clineuro.2017.04.012_bib0175","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/eji.201445064","article-title":"IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis","volume":"45","author":"Schaffert","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.clineuro.2017.04.012_bib0180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/ACI.0000000000000009","article-title":"B-cell memory and primary immune deficiencies: interleukin-21 related defects","volume":"13","author":"Desjardins","year":"2013","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00726-011-1192-8","article-title":"Modulation of inflammatory pathways by the immune cholinergic system","volume":"45","author":"Nizri","year":"2013","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.clineuro.2017.04.012_bib0190","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clineuro.2017.04.012_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clineuro.2017.04.012_bib0200","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2017.04.012_bib0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2015.03.003","article-title":"Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-\u03baB1","volume":"165","author":"Park","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clineuro.2017.04.012_bib0210","doi-asserted-by":"crossref","first-page":"20156","DOI":"10.1038\/srep20156","article-title":"Rapamycin attenuates acute lung injury induced by LPS through inhibition of Th17 cell proliferation in mice","volume":"6","author":"Yan","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2017.04.012_bib0215","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4049\/jimmunol.167.4.1871","article-title":"Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide","volume":"167","author":"Denlinger","year":"2001","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.clineuro.2017.04.012_bib0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1096\/fj.08-114637","article-title":"Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts","volume":"23","author":"Gonnord","year":"2009","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.clineuro.2017.04.012_bib0225","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/BC20090138","article-title":"Host-cell lipid rafts: a safe door for micro-organisms?","volume":"102","author":"Vieira","year":"2010","journal-title":"Biol. Cell."},{"issue":"8","key":"10.1016\/j.clineuro.2017.04.012_bib0230","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.4049\/jimmunol.1202045","article-title":"Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis","volume":"190","author":"Killeen","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.clineuro.2017.04.012_bib0235","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.112.123653","article-title":"Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7","volume":"127","author":"Vergani","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.clineuro.2017.04.012_bib0240","first-page":"1512","article-title":"Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis","volume":"14","author":"Killeen","year":"2014","journal-title":"Am. J. Transplant."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846717301087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846717301087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T05:49:37Z","timestamp":1569044977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846717301087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":48,"alternative-id":["S0303846717301087"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2017.04.012","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}